Sublingual Sufentanil versus Standard-of-Care (Patient-Controlled Analgesia with Epidural Ropivacaine/Sufentanil or Intravenous Morphine) for Postoperative Pain Following Pancreatoduodenectomy: A Randomized Trial
DOI: https://doi.org/10.2147/JPR.S363545
IF: 2.8319
2022-06-22
Journal of Pain Research
Abstract:Jesse Vincent Groen, 1 SC Boon, 2 MW Minderhoud, 2 Bert A Bonsing, 1 CH Martini, 2 H Putter, 3 AL Vahrmeijer, 1 Monique van Velzen, 2 J Vuijk, 2 JSD Mieog, 1, &ast A Dahan 2, &ast 1 Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; 2 Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands; 3 Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands &astThese authors contributed equally to this work Correspondence: A Dahan, Department of Anesthesiology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300 RC, The Netherlands, Tel +31 71 526 2301, Email Background: The optimal treatment strategy for postoperative pain following pancreatoduodenectomy remains unknown. The aim of this study was to investigate whether sublingual sufentanil tablet (SST) is a non-inferior analgesic compared to our standard-of-care (patient-controlled epidural analgesia [PCEA] or PCA morphine) in the treatment of pain following pancreatoduodenectomy. Methods: This was a pragmatic, strategy, open-label, non-inferiority, parallel group, randomized (1:1) trial. The primary outcome was an overall mean pain score (Numerical Rating Scale: 0– 10) on postoperative days 1 to 3 combined. The non-inferiority margin was − 1.5 since this difference was considered clinically relevant. Results: Between October 2018 and July 2021, 190 patients were assessed for eligibility and 36 patients were included in the final analysis: 17 patients were randomized to SST and 19 patients to standard-of-care. Early treatment failure in the SST group occurred in 2 patients (12%) due to inability to operate the SST system and in 2 patients (12%) due to severe nausea despite antiemetics. Early treatment failure in the standard-of-care group occurred in 2 patients (11%) due to preoperative PCEA placement failure and in 1 patient (5%) due to hemodynamic instability caused by PCEA. The mean difference in pain score on postoperative day 1 to 3 was − 0.10 (95% CI − 0.72– 0.52), and therefore the non-inferiority of SST compared to standard-of-care was demonstrated. The mean pain score, number of patients reporting unacceptable pain (pain score > 4), Overall Benefit of Analgesia Score, and patient satisfaction per postoperative day, perioperative hemodynamics and postoperative outcomes did not differ significantly between groups. Conclusion: This first randomized study investigating the use of SST in 36 patients following pancreatoduodenectomy showed that SST is non-inferior compared to our standard-of-care in the treatment of pain on postoperative days 1 to 3. Future research is needed to confirm that these findings are applicable to other settings. Keywords: postoperative pain, pancreatoduodenectomy, sufentanil, epidural analgesia, morphine Epidural analgesia (EA) is the gold standard for perioperative analgesic management in most major open abdominal surgeries. 1 Recently, we performed a systematic review of the various analgesic treatment strategies after pancreatoduodenectomy in our own center 2 and in the current literature. 3 The reported use of EA in patients undergoing pancreatoduodenectomy varies from 9% to 85%. 3 The potential benefits of EA are lower pain scores in the first postoperative days and fewer postoperative (pulmonary) complications. 2,3 The disadvantages of EA are the invasive nature, early failure rates, hemodynamic instability and notorious, albeit uncommon, complications (eg spinal hematoma and epidural infections). 2–6 The most used alternative to EA is intravenous (iv) morphine. 1–3,7 _ENREF_3 The advantages of iv morphine are that most patients are eligible (eg patients with coagulation disorders or spine anatomy alterations) and that it is a less invasive method compared to EA. The disadvantages of iv morphine are the suboptimal pain control and a higher consumption of opioids compared to EA with associated side effects. 2,3,8 The anesthesia and surgical teams at our center recently concluded that our standard-of-care treatment strategies following pancreatoduodenectomy were currently not comprehensive, and hence alternatives are explored. Among the available alternatives for EA and iv morphine is sublingual sufentanil tablets (SST). _ENREF_9 SST consists of a patient-controlled non-invasive hand-held device that delivers 15 μg sufentanil micro-tablets with a 20 min lockout time. The advantages of SST are as follows: (1) it is a non-invasive method of analgesia; (2) sufentanil is highly lipop -Abstract Truncated-
clinical neurology